AssetMark Inc’s Abivax ABVX Stock Holding History

AssetMark Inc’s Portfolio ABVX Stock Details ABVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$98.9K	Sell	742 -144	-16%	-$16.3K	﹤0.01%	1628
2026 Q1	$98.7K	Buy	886 +260	+42%	+$30.8K	﹤0.01%	1547
2025 Q4	$84.4K	Buy	+626	New	+$68.3K	﹤0.01%	1556

Other funds holding ABVX

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

NFT

Nan Fung Trinity Central, Hong Kong, Hong Kong $1.01B AUM 64.38% 1-Year Est. Return

ACM

ACT Capital Management Wayne, Pennsylvania $153M AUM

EAM

Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return

Andera Partners Paris $206M AUM

Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return

HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return

SCS

Syquant Capital SAS Paris, France $447M AUM 13.04% 1-Year Est. Return

AssetMark Inc's ABVX Position: Q2 2026 in Review

AssetMark Inc reduced its Abivax (ABVX) stake by 16% in Q2 2026, selling an estimated $16.3K and leaving 742 shares worth $98.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

AssetMark Inc first reported a position in ABVX in Q4 2025 and has held it in 3 quarters since. 67 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.

AssetMark Inc held 742 shares of Abivax worth $98.9K as of Q2 2026.
AssetMark Inc sold 144 Abivax shares in Q2 2026, an estimated $16.3K.
Abivax made up ﹤0.01% of AssetMark Inc's portfolio in Q2 2026, its #1628 holding.
AssetMark Inc first reported a position in Abivax in Q4 2025 and has held it in 3 quarters since.
67 funds tracked by Wall St. Rank held Abivax as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.